NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/26/2024
Back to search
Official data from USPTO
SYNTHIA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SYNTHIA
ST13
US500000087825579Class
9, 38, 42, 45
Filing
87825579
Registration
7575011
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
59
Latest update
11/26/2024
Trademark type
Word
Nice classes
9, 38, 42, 45
Filing date
03/08/2018
Registration date
11/26/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/26/2024
Last transaction
11/26/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
Darmstadt, DE
Examiner
HOWELL,MATTHEW PATTERSON
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Merck KGaA
Representatives
William C. Wright EPSTEIN DRANGEL LLP
Technical classification
Nice Classes
Class 9Class 38Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Electronic databases in the fields of drug development and drug manufacturingrecorded on computer media; bioinformatics software for storingindexingsearchingretrievingaccessing information about biological data for use in retrosynthesisoptimization of organic chemistry reactions and synthesisassessing synthetic accessibility of real and virtual moleculesdrug discoverydrug developmentdrug manufacturing; chemoinformatics software for storingindexingsearchingretrievingaccessing information about chemical compounds and chemical data for use in retrosynthesisoptimization of organic chemistry reactions and synthesisassessing synthetic accessibility of real and virtual moleculesdrug discoverydrug developmentdrug manufacturing; software for use in biological and chemical modellinganalysis and information management for use in retrosynthesisoptimization of organic chemistry reactions and synthesisassessing synthetic accessibility of real and virtual moleculesdrug discoverydrug developmentdrug manufacturing; software for computer-aided molecular designdata processing and data analysis for use in retrosynthesisoptimization of organic chemistry reactions and synthesisassessing synthetic accessibility of real and virtual moleculesdrug discoverydrug developmentdrug manufacturing; chemical data analysis software for use in retrosynthesisoptimization of organic chemistry reactions and synthesisassessing synthetic accessibility of real and virtual moleculesdrug discoverydrug developmentdrug manufacturing; drug discovery information systems software used to solve problems in connection with chemical syntheses for use in the field of organic chemistry; none of the foregoing for use in connection with synthetic patientssimulated patientssynthetic electronic patient healthcare recordssynthetic patient data and associated healthcare recordsnor in the field of medical science and medical consultancy
Class 38
Providing access to databases for use in retrosynthesisoptimization of organic chemistry reactions and synthesisassessing synthetic accessibility of real and virtual moleculesdrug discoverydrug developmentdrug manufacturing; none of the foregoing for use in connection with synthetic patientssimulated patientssynthetic electronic patient healthcare recordssynthetic patient data and associated healthcare recordsnor in the field of medical science and medical consultancy
Class 42
Biotechnology and pharmaceutical research relating to retrosynthesisoptimization of organic chemistry reactions and synthesisassessing synthetic accessibility of real and virtual moleculesdrug development; professional consultancy in relation to drug development; scientific research and development for others; scientific research in the nature of analysis and preparation of data relating to retrosynthesisoptimization of organic chemistry reactions and synthesisassessing synthetic accessibility of real and virtual moleculesdrug discovery and drug development; provision of information in relation to drug discovery and drug development; provision of scientific information related to pharmacy; none of the foregoing for use in connection with synthetic patientssimulated patientssynthetic electronic patient healthcare recordssynthetic patient data and associated healthcare recordsnor in the field of medical science and medical consultancy
Class 45
Licensing of computer software used for retrosynthesisoptimization of organic chemistry reactions and synthesisassessing synthetic accessibility of real and virtual moleculesdrug discoverydrug developmentdrug manufacturing; none of the foregoing for use in connection with synthetic patientssimulated patientssynthetic electronic patient healthcare recordssynthetic patient data and associated healthcare recordsnor in the field of medical science and medical consultancy
Publications
History of USPTO decisions and trademark events.
59 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/26/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/24/2024
PUBO
PUBLISHED FOR OPPOSITION
09/24/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/04/2024
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
08/15/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/13/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/13/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/13/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
07/13/2024
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
04/15/2024
GNSI
INQUIRY TO SUSPENSION E-MAILED
04/15/2024
CNSI
SUSPENSION INQUIRY WRITTEN
04/15/2024
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
04/12/2024
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
10/11/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
10/11/2023
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
03/03/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
03/02/2023
DOCK
ASSIGNED TO EXAMINER
02/14/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
11/30/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
04/28/2022
GNSL
LETTER OF SUSPENSION E-MAILED
04/28/2022
CNSL
SUSPENSION LETTER WRITTEN
04/28/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/21/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/21/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/21/2022
DOCK
ASSIGNED TO EXAMINER
11/03/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/23/2021
GNRT
NON-FINAL ACTION E-MAILED
08/23/2021
CNRT
NON-FINAL ACTION WRITTEN
08/23/2021
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
06/26/2021
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
06/23/2020
ALIE
ASSIGNED TO LIE
06/22/2020
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
12/20/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
06/10/2019
GNSL
LETTER OF SUSPENSION E-MAILED
06/10/2019
CNSL
SUSPENSION LETTER WRITTEN
06/10/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/20/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/20/2019
ALIE
ASSIGNED TO LIE
05/16/2019
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
05/09/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/19/2019
GNSL
LETTER OF SUSPENSION E-MAILED
03/19/2019
CNSL
SUSPENSION LETTER WRITTEN
03/19/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/12/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/11/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/11/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/08/2018
GNRT
NON-FINAL ACTION E-MAILED
11/08/2018
CNRT
NON-FINAL ACTION WRITTEN
11/08/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/02/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/02/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/02/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/04/2018
GNRT
NON-FINAL ACTION E-MAILED
04/04/2018
CNRT
NON-FINAL ACTION WRITTEN
04/04/2018
DOCK
ASSIGNED TO EXAMINER
03/27/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/14/2018
NWAP
NEW APPLICATION ENTERED
03/12/2018
Continuous trademark protection
Get notified about every new filing that threatens SYNTHIA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.